Transcode CFO granted 185K options at $1.78
The CFO of RNAZ was granted 185,000 stock options vesting monthly over one year at a $1.78 exercise price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Transcode Therapeutics, Inc. (RNAZ) reported that its Chief Financial Officer, Thomas A. Fitzgerald, received a grant of 185,000 stock options on September 9, 2026. These options have an exercise price of $1.78 per share and will vest in twelve equal monthly installments following the grant date, expiring on September 8, 2036.
Insider Trade Summary
Grant/Award: 185,000 shares
Grant/Award
1 txn
Insider
Fitzgerald Thomas A
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 185,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 185,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest and become exercisable in twelve (12) equal monthly installments following the grant date.
Key Figures
Stock options granted: 185,000 options
Exercise price: $1.78 per share
Underlying common shares: 185,000 shares
+3 more
6 metrics
Stock options granted
185,000 options
Grant to the CFO on September 9, 2026
Exercise price
$1.78 per share
Exercise price of the granted stock options
Underlying common shares
185,000 shares
Shares of common stock underlying the options
Options held after transaction
185,000 options
Total derivative securities held directly by the CFO after the grant
Vesting schedule length
12 monthly installments
Options vest in twelve equal monthly installments following the grant date
Option expiration date
September 8, 2036
Expiration date of the granted stock options
Key Terms
Stock Option (right to buy), exercise price, vesting, twelve (12) equal monthly installments
4 terms
Stock Option (right to buy) financial
"security titled "Stock Option (right to buy)" was granted to the CFO"
exercise price financial
"These options have an exercise price of $1.78 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shall vest and become exercisable in twelve equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
twelve (12) equal monthly installments financial
"shall vest and become exercisable in twelve (12) equal monthly installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RNAZ disclose for its CFO?
RNAZ disclosed that Chief Financial Officer Thomas A. Fitzgerald received a grant of 185,000 stock options on September 9, 2026, as a compensation-related award, with all options held directly after the grant.
What is the exercise price of the newly granted RNAZ stock options?
The newly granted stock options to RNAZ’s CFO have an exercise price of $1.78 per share, meaning each option allows the purchase of one share of common stock at $1.78 when exercised, subject to vesting.
How do the 185,000 RNAZ stock options vest for the CFO?
The 185,000 stock options granted to the RNAZ CFO vest in twelve equal monthly installments following the grant date, as disclosed, so vesting occurs gradually over the first year after September 9, 2026.
When do the newly granted RNAZ stock options expire?
The stock options granted to the RNAZ CFO expire on September 8, 2036, giving a ten-year term from the grant date during which vested options may be exercised, subject to the award’s other terms.
How many RNAZ derivative securities does the CFO hold after this Form 4 transaction?
After this reported transaction, the RNAZ CFO holds 185,000 stock options directly, corresponding to rights to acquire up to 185,000 shares of common stock upon exercise, subject to vesting and other plan conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
